<VariationArchive VariationID="197412" VariationName="NM_004006.3(DMD):c.5697del (p.Lys1899fs)" VariationType="Deletion" Accession="VCV000197412" Version="10" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-23" DateCreated="2015-06-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="194573" VariationID="197412">
      <GeneList>
        <Gene Symbol="DMD" FullName="dystrophin" GeneID="1756" HGNC_ID="HGNC:2928" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.2-21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="31119222" stop="33339388" display_start="31119222" display_stop="33339388" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="31137344" stop="33357725" display_start="31137344" display_stop="33357725" Strand="-" />
          </Location>
          <OMIM>300377</OMIM>
          <Haploinsufficiency last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004006.3(DMD):c.5697del (p.Lys1899fs)</Name>
      <CanonicalSPDI>NC_000023.11:32343175:TTTTTTTT:TTTTTTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="32343176" stop="32343176" display_start="32343176" display_stop="32343176" variantLength="1" positionVCF="32343175" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="32361293" stop="32361293" display_start="32361293" display_stop="32361293" variantLength="1" positionVCF="32361292" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>NM_004006.3(DMD):c.5697del</Name>
        <Name>p.Lys1899fs</Name>
      </OtherNameList>
      <ProteinChange>K1891fs</ProteinChange>
      <ProteinChange>K1895fs</ProteinChange>
      <ProteinChange>K1776fs</ProteinChange>
      <ProteinChange>K555fs</ProteinChange>
      <ProteinChange>K1899fs</ProteinChange>
      <ProteinChange>K558fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.32361300del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.32361300del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.32343183del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.32343183del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012232.1" sequenceAccession="NG_012232" sequenceVersion="1" change="g.1001434del">
            <Expression>NG_012232.1:g.1001434del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000109.4" sequenceAccession="NM_000109" sequenceVersion="4" change="c.5673del">
            <Expression>NM_000109.4:c.5673del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000100.3" sequenceAccession="NP_000100" sequenceVersion="3" change="p.Lys1891fs">
            <Expression>NP_000100.3:p.Lys1891fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004006.3" sequenceAccession="NM_004006" sequenceVersion="3" change="c.5697del" MANESelect="true">
            <Expression>NM_004006.3:c.5697del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003997.2" sequenceAccession="NP_003997" sequenceVersion="2" change="p.Lys1899fs">
            <Expression>NP_003997.2:p.Lys1899fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004009.3" sequenceAccession="NM_004009" sequenceVersion="3" change="c.5685del">
            <Expression>NM_004009.3:c.5685del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004000.1" sequenceAccession="NP_004000" sequenceVersion="1" change="p.Lys1895fs">
            <Expression>NP_004000.1:p.Lys1895fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004010.3" sequenceAccession="NM_004010" sequenceVersion="3" change="c.5328del">
            <Expression>NM_004010.3:c.5328del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004001.1" sequenceAccession="NP_004001" sequenceVersion="1" change="p.Lys1776fs">
            <Expression>NP_004001.1:p.Lys1776fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004011.4" sequenceAccession="NM_004011" sequenceVersion="4" change="c.1674del">
            <Expression>NM_004011.4:c.1674del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004002.3" sequenceAccession="NP_004002" sequenceVersion="3" change="p.Lys558fs">
            <Expression>NP_004002.3:p.Lys558fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004012.4" sequenceAccession="NM_004012" sequenceVersion="4" change="c.1665del">
            <Expression>NM_004012.4:c.1665del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004003.2" sequenceAccession="NP_004003" sequenceVersion="2" change="p.Lys555fs">
            <Expression>NP_004003.2:p.Lys555fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_199" sequenceAccession="LRG_199">
            <Expression>LRG_199:g.1001434del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004006.2" sequenceAccession="NM_004006" sequenceVersion="2" change="c.5697delA">
            <Expression>NM_004006.2:c.5697delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA275266" DB="ClinGen" />
        <XRef Type="rs" ID="794727661" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004006.3(DMD):c.5697del (p.Lys1899fs) AND not provided" Accession="RCV000483538" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2017-08-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004006.3(DMD):c.5697del (p.Lys1899fs) AND multiple conditions" Accession="RCV001832024" Version="1">
        <ClassifiedConditionList TraitSetID="53078">
          <ClassifiedCondition DB="MedGen" ID="C0917713">Becker muscular dystrophy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0878544">Cardiomyopathy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0013264">Duchenne muscular dystrophy</ClassifiedCondition>
          <ClassifiedCondition>Dystrophin deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-06-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004006.3(DMD):c.5697del (p.Lys1899fs) AND Duchenne muscular dystrophy" Accession="RCV002250589" Version="3">
        <ClassifiedConditionList TraitSetID="3094">
          <ClassifiedCondition DB="MedGen" ID="C0013264">Duchenne muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-07-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004006.3(DMD):c.5697del (p.Lys1899fs) AND Duchenne and Becker muscular dystrophy" Accession="RCV003225932" Version="3">
        <ClassifiedConditionList TraitSetID="79214">
          <ClassifiedCondition DB="MedGen" ID="C3542021">Duchenne and Becker muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-02" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2015-06-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16770791</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19409785</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25007885</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31727011</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.dmd.nl/nmdb2/variants.php?select_db=DMD&amp;action=search_all&amp;search_Variant%2FDNA=c.5697delA</URL>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=DMD</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="79214" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="49400" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Duchenne and Becker muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0016899" DB="MONDO" />
              </Name>
              <XRef ID="262" DB="Orphanet" />
              <XRef ID="C3542021" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="53078" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3056" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Becker muscular dystrophy</ElementValue>
                <XRef ID="Becker+Muscular+Dystrophy/771" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010311" DB="MONDO" />
                <XRef ID="387732009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Benign pseudohypertrophic muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker's muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy pseudohypertrophic progressive, Becker type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BMD</ElementValue>
                <XRef Type="MIM" ID="300376" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5900" />
                <XRef ID="5900" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker muscular dystrophy, and DMD-associated dilated cardiomyopathy (DCM). The mild end of the spectrum includes the phenotypes of asymptomatic increase in serum concentration of creatine phosphokinase (CK) and muscle cramps with myoglobinuria. The severe end of the spectrum includes progressive muscle diseases that are classified as Duchenne/Becker muscular dystrophy when skeletal muscle is primarily affected and as DMD-associated DCM when the heart is primarily affected. Duchenne muscular dystrophy (DMD) usually presents in early childhood with delayed motor milestones including delays in walking independently and standing up from a supine position. Proximal weakness causes a waddling gait and difficulty climbing stairs, running, jumping, and standing up from a squatting position. DMD is rapidly progressive, with affected children being wheelchair dependent by age 12 years. Cardiomyopathy occurs in almost all individuals with DMD after age 18 years. Few survive beyond the third decade, with respiratory complications and progressive cardiomyopathy being common causes of death. Becker muscular dystrophy (BMD) is characterized by later-onset skeletal muscle weakness. With improved diagnostic techniques, it has been recognized that the mild end of the spectrum includes men with onset of symptoms after age 30 years who remain ambulatory even into their 60s. Despite the milder skeletal muscle involvement, heart failure from DCM is a common cause of morbidity and the most common cause of death in BMD. Mean age of death is in the mid-40s. DMD-associated DCM is characterized by left ventricular dilation and congestive heart failure. Females heterozygous for a DMD pathogenic variant are at increased risk for DCM.</Attribute>
                <XRef ID="NBK1119" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="general" Abbrev="AAP, 2005">
                <ID Source="PubMed">16322188</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301298</ID>
                <ID Source="BookShelf">NBK1119</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2017">
                <ID Source="PubMed">25313375</ID>
                <ID Source="pmc">4206155</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/DMD_Pathogenic_Variants.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Pathogenic Variant in Dystrophin (DMD Gene) and elevated creatine kinase muscle isoform (CK-MM), Duchenne and Becker Muscular Dystrophy, 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_CKMM.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated creatine kinase muscle isoform (CKMM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/DMD-Elevated-CKMM-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, ELEVATED CREATINEKINASE(CK)-MM , Genetic Neuromuscular Disorders, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_No_Pathogenic_Variant.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, No Pathogenic Variant in Dystrophin (DMD) Gene after elevated creatine kinase muscle isoform (CK-MM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Duchenne-Becker-Muscular-Dystrophy.pdf</URL>
                <CitationText>American College of Medical Genetics &amp;amp; Genomics Genetic Testing ACT Sheet, Duchenne and Becker Muscular Dystrophy, 2012</CitationText>
              </Citation>
              <XRef ID="98895" DB="Orphanet" />
              <XRef ID="C0917713" DB="MedGen" />
              <XRef ID="MONDO:0010311" DB="MONDO" />
              <XRef Type="MIM" ID="300376" DB="OMIM" />
            </Trait>
            <Trait ID="43789" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dystrophin deficiency</ElementValue>
              </Name>
            </Trait>
            <Trait ID="10877" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Duchenne muscular dystrophy</ElementValue>
                <XRef ID="Duchenne+Muscular+Dystrophy/2340" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010679" DB="MONDO" />
                <XRef ID="76670001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, pseudohypertrophic progressive, Duchenne type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DMD</ElementValue>
                <XRef Type="MIM" ID="310200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6291" />
                <XRef ID="6291" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker muscular dystrophy, and DMD-associated dilated cardiomyopathy (DCM). The mild end of the spectrum includes the phenotypes of asymptomatic increase in serum concentration of creatine phosphokinase (CK) and muscle cramps with myoglobinuria. The severe end of the spectrum includes progressive muscle diseases that are classified as Duchenne/Becker muscular dystrophy when skeletal muscle is primarily affected and as DMD-associated DCM when the heart is primarily affected. Duchenne muscular dystrophy (DMD) usually presents in early childhood with delayed motor milestones including delays in walking independently and standing up from a supine position. Proximal weakness causes a waddling gait and difficulty climbing stairs, running, jumping, and standing up from a squatting position. DMD is rapidly progressive, with affected children being wheelchair dependent by age 12 years. Cardiomyopathy occurs in almost all individuals with DMD after age 18 years. Few survive beyond the third decade, with respiratory complications and progressive cardiomyopathy being common causes of death. Becker muscular dystrophy (BMD) is characterized by later-onset skeletal muscle weakness. With improved diagnostic techniques, it has been recognized that the mild end of the spectrum includes men with onset of symptoms after age 30 years who remain ambulatory even into their 60s. Despite the milder skeletal muscle involvement, heart failure from DCM is a common cause of morbidity and the most common cause of death in BMD. Mean age of death is in the mid-40s. DMD-associated DCM is characterized by left ventricular dilation and congestive heart failure. Females heterozygous for a DMD pathogenic variant are at increased risk for DCM.</Attribute>
                <XRef ID="NBK1119" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="general" Abbrev="Updated, AAN/CNS, 2005">
                <ID Source="PubMed">15642897</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2005">
                <ID Source="PubMed">16322188</ID>
              </Citation>
              <Citation Type="general" Abbrev="DMD Management and Anesthesia - ACCP, 2007">
                <ID Source="PubMed">18079231</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                <ID Source="PubMed">19945913</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                <ID Source="PubMed">19945914</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301298</ID>
                <ID Source="BookShelf">NBK1119</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC Respiratory Panel, 2010">
                <ID Source="PubMed">20597083</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_DuchenneMuscularDystrophy-enPro13913.pdf</URL>
                <CitationText>Orphanet, Duchenne muscular dystrophy, 2013</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2022">
                <ID Source="PubMed">26833937</ID>
                <ID Source="pmc">4773944</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29395990</ID>
                <ID Source="pmc">5889091</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29398641</ID>
                <ID Source="pmc">5902408</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29395989</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/DMD_Pathogenic_Variants.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Pathogenic Variant in Dystrophin (DMD Gene) and elevated creatine kinase muscle isoform (CK-MM), Duchenne and Becker Muscular Dystrophy, 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_CKMM.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated creatine kinase muscle isoform (CKMM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/DMD-Elevated-CKMM-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, ELEVATED CREATINEKINASE(CK)-MM , Genetic Neuromuscular Disorders, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_No_Pathogenic_Variant.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, No Pathogenic Variant in Dystrophin (DMD) Gene after elevated creatine kinase muscle isoform (CK-MM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Duchenne-Becker-Muscular-Dystrophy.pdf</URL>
                <CitationText>American College of Medical Genetics &amp;amp; Genomics Genetic Testing ACT Sheet, Duchenne and Becker Muscular Dystrophy, 2012</CitationText>
              </Citation>
              <XRef ID="98896" DB="Orphanet" />
              <XRef ID="C0013264" DB="MedGen" />
              <XRef ID="MONDO:0010679" DB="MONDO" />
              <XRef Type="MIM" ID="310200" DB="OMIM" />
            </Trait>
            <Trait ID="16502" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cardiomyopathies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cardiomyopathy</ElementValue>
                <XRef ID="Cardiomyopathy/1090" DB="Genetic Alliance" />
                <XRef ID="HP:0001638" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0004994" DB="MONDO" />
                <XRef ID="85898001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMYO</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Various modes of inheritance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11958" />
                <XRef ID="11958" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="167848" DB="Orphanet" />
              <XRef ID="C0878544" DB="MedGen" />
              <XRef ID="MONDO:0004994" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001638" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3094" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10877" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Duchenne muscular dystrophy</ElementValue>
                <XRef ID="Duchenne+Muscular+Dystrophy/2340" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010679" DB="MONDO" />
                <XRef ID="76670001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, pseudohypertrophic progressive, Duchenne type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DMD</ElementValue>
                <XRef Type="MIM" ID="310200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6291" />
                <XRef ID="6291" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker muscular dystrophy, and DMD-associated dilated cardiomyopathy (DCM). The mild end of the spectrum includes the phenotypes of asymptomatic increase in serum concentration of creatine phosphokinase (CK) and muscle cramps with myoglobinuria. The severe end of the spectrum includes progressive muscle diseases that are classified as Duchenne/Becker muscular dystrophy when skeletal muscle is primarily affected and as DMD-associated DCM when the heart is primarily affected. Duchenne muscular dystrophy (DMD) usually presents in early childhood with delayed motor milestones including delays in walking independently and standing up from a supine position. Proximal weakness causes a waddling gait and difficulty climbing stairs, running, jumping, and standing up from a squatting position. DMD is rapidly progressive, with affected children being wheelchair dependent by age 12 years. Cardiomyopathy occurs in almost all individuals with DMD after age 18 years. Few survive beyond the third decade, with respiratory complications and progressive cardiomyopathy being common causes of death. Becker muscular dystrophy (BMD) is characterized by later-onset skeletal muscle weakness. With improved diagnostic techniques, it has been recognized that the mild end of the spectrum includes men with onset of symptoms after age 30 years who remain ambulatory even into their 60s. Despite the milder skeletal muscle involvement, heart failure from DCM is a common cause of morbidity and the most common cause of death in BMD. Mean age of death is in the mid-40s. DMD-associated DCM is characterized by left ventricular dilation and congestive heart failure. Females heterozygous for a DMD pathogenic variant are at increased risk for DCM.</Attribute>
                <XRef ID="NBK1119" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="general" Abbrev="Updated, AAN/CNS, 2005">
                <ID Source="PubMed">15642897</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2005">
                <ID Source="PubMed">16322188</ID>
              </Citation>
              <Citation Type="general" Abbrev="DMD Management and Anesthesia - ACCP, 2007">
                <ID Source="PubMed">18079231</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                <ID Source="PubMed">19945913</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                <ID Source="PubMed">19945914</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301298</ID>
                <ID Source="BookShelf">NBK1119</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC Respiratory Panel, 2010">
                <ID Source="PubMed">20597083</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_DuchenneMuscularDystrophy-enPro13913.pdf</URL>
                <CitationText>Orphanet, Duchenne muscular dystrophy, 2013</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2022">
                <ID Source="PubMed">26833937</ID>
                <ID Source="pmc">4773944</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29395990</ID>
                <ID Source="pmc">5889091</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29398641</ID>
                <ID Source="pmc">5902408</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29395989</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/DMD_Pathogenic_Variants.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Pathogenic Variant in Dystrophin (DMD Gene) and elevated creatine kinase muscle isoform (CK-MM), Duchenne and Becker Muscular Dystrophy, 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_CKMM.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated creatine kinase muscle isoform (CKMM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/DMD-Elevated-CKMM-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, ELEVATED CREATINEKINASE(CK)-MM , Genetic Neuromuscular Disorders, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_No_Pathogenic_Variant.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, No Pathogenic Variant in Dystrophin (DMD) Gene after elevated creatine kinase muscle isoform (CK-MM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Duchenne-Becker-Muscular-Dystrophy.pdf</URL>
                <CitationText>American College of Medical Genetics &amp;amp; Genomics Genetic Testing ACT Sheet, Duchenne and Becker Muscular Dystrophy, 2012</CitationText>
              </Citation>
              <XRef ID="98896" DB="Orphanet" />
              <XRef ID="C0013264" DB="MedGen" />
              <XRef ID="MONDO:0010679" DB="MONDO" />
              <XRef Type="MIM" ID="310200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1100873" SubmissionDate="2019-01-29" DateLastUpdated="2018-12-15" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:125327|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000565766" DateUpdated="2018-12-15" DateCreated="2017-04-27" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.5697delA pathogenic variant has been reported previously in association with dystrophinopathy (Almomani et al., 2009). The variant causes a frameshift starting with codon Lysine 1899, changes this amino acid to a Asparagine residue and creates a premature Stop codon at position 2 of the new reading frame, denoted p.Lys1899AsnfsX2. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Furthermore, the c.5697delA variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004006.2:c.5697delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4082979" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_004006.3:c.5697del|Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy;Dystrophin deficiency" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002093469" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004006.3:c.5697del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Becker muscular dystrophy</ElementValue>
            </Name>
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cardiomyopathy</ElementValue>
            </Name>
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Duchenne muscular dystrophy</ElementValue>
            </Name>
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Dystrophin deficiency</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4940528" SubmissionDate="2022-05-28" DateLastUpdated="2022-06-03" DateCreated="2022-06-03">
        <ClinVarSubmissionID localKey="X-32361292-AT-A" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002521434" DateUpdated="2022-06-03" DateCreated="2022-06-03" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19409785</ID>
          </Citation>
          <Comment>The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000197412 / PMID: 19409785). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0030051" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003701" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001265" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003236" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004006.3:c.5697del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="310200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11507599</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7332557" SubmissionDate="2023-05-03" DateLastUpdated="2023-05-06" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="d2da183c-b320-426b-b215-f64ff3b5c13e" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003922283" DateUpdated="2023-05-06" DateCreated="2023-05-06" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The hemizygous p.Lys1899AsnfsTer2 variant in DMD was identified by our study in one individual with Duchenne muscular dystrophy. Trio exome analysis showed this variant to be de novo. The p.Lys1899AsnfsTer2 variant in DMD has been previously reported in at least 6 unrelated individuals with DMD-associated muscular dystrophy (PMID: 28116794, PMID: 29973226, PMID: 35218518, PMID: 19409785, PMID: 31727011, ClinVar SCV002521434.1). The number of reported affected individuals with this variant is greater than expected compared to non-affected individuals with this variant. This variant has also been reported in ClinVar (Variation ID: 197412) and has been interpreted as pathogenic by Invitae, GeneDx, Eurofins NTD LLC, 3Billion, and Natera, Inc. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 1899 and leads to a premature termination codon 2 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the DMD gene is an established disease mechanism in X-linked DMD-associated muscular dystrophy. In summary, this variant meets criteria to be classified as pathogenic for X-linked DMD-associated muscular dystrophy. ACMG/AMP Criteria applied: PVS1, PS4, PM2_Supporting (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_004006.3(DMD):c.5697del</Name>
            <Name>p.Lys1899fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.11:g.32343183del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0016899" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13232620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6133404" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4967860|MedGen:C0013264" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003445058" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19409785</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31727011</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16770791</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25007885</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 197412). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with Duchenne muscular dystrophy (PMID: 19409785, 31727011). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys1899Asnfs*2) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.32361293del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0013264" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="418836" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="20399_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000230514" DateUpdated="2018-12-15" DateCreated="2015-06-28" Type="SCV" Version="5" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000230513" DateChanged="2019-08-06" Version="4">
            <Comment Type="MergeComment">SCV000230513 was merged into SCV000230514 to remove duplication.</Comment>
          </Replaced>
          <Replaced Accession="SCV000230512" DateChanged="2019-08-06" Version="4">
            <Comment Type="MergeComment">SCV000230512 was merged into SCV000230514 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2014-06-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>http://www.dmd.nl/nmdb2/variants.php?select_db=DMD&amp;action=search_all&amp;search_Variant%2FDNA=c.5697delA</URL>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DMD" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="X" alternateAllele="-" referenceAllele="T" start="32361293" stop="32361293" variantLength="1" />
            <GeneLocation>NM_004006.2:Ex40</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD093452" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=DMD</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4082979" TraitType="Disease" MappingType="Name" MappingValue="Becker muscular dystrophy" MappingRef="Preferred">
        <MedGen CUI="C0917713" Name="Becker muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="418836" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940528" TraitType="Finding" MappingType="XRef" MappingValue="HP:0030051" MappingRef="HP">
        <MedGen CUI="C0427144" Name="Tip-toe gait" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940528" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001265" MappingRef="HP">
        <MedGen CUI="C0700078" Name="Hyporeflexia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4082979" TraitType="Disease" MappingType="Name" MappingValue="Dystrophin deficiency" MappingRef="Preferred">
        <MedGen CUI="None" Name="Dystrophin deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6133404" TraitType="Disease" MappingType="XRef" MappingValue="C0013264" MappingRef="MedGen">
        <MedGen CUI="C0013264" Name="Duchenne muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4082979" TraitType="Disease" MappingType="Name" MappingValue="Cardiomyopathy" MappingRef="Preferred">
        <MedGen CUI="C0878544" Name="Cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940528" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003236" MappingRef="HP">
        <MedGen CUI="C0241005" Name="Elevated circulating creatine kinase concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4082979" TraitType="Disease" MappingType="Name" MappingValue="Duchenne muscular dystrophy" MappingRef="Preferred">
        <MedGen CUI="C0013264" Name="Duchenne muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940528" TraitType="Disease" MappingType="XRef" MappingValue="310200" MappingRef="OMIM">
        <MedGen CUI="C0013264" Name="Duchenne muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940528" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003701" MappingRef="HP">
        <MedGen CUI="C0221629" Name="Proximal muscle weakness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1100873" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

